Latest: Q2 2026 · from the cash-flow statements filed with the SEC
Free cash flow−$3.1M in Q2 2026 · −$7.0M over twelve months
Operating cash flow−$3.1M
Capital spending−$8K
Free cash flow−$3.1M
Cash conversion cycle915 days
Analysis
In Q2 2026, Sensus Healthcare generated −$3.1M of operating cash flow and spent $8K on capital projects, leaving free cash flow of −$3.1M. That is $6.2M less than in Q2 2025 ($3.1M).
Over the twelve months to Jun 30, 2026, operating cash flow was −$6.8M; the largest uses were operating cash flow ($6.8M), capital spending ($173K); the cash balance fell by $7.0M.
Operating cash flow was −$3.1M against net income of −$8.7M. The largest differences: deferred taxes +$5.7M, inventory −$2.5M, receivables +$1.9M.
Its cash conversion cycle was 915 days (receivables 104 + inventory 1046 − payables 235).
Free cash flow
Operating cash flow less capital spending.Latest (Q2 2026): Operating cash flow −$3.1M, Capital spending $8K.
Capital allocation, year by year
Over these 5 years operating cash flow totalled −$4.1M; the largest uses were operating cash flow ($4.7M) and buybacks ($3.3M). Cash-flow statements as filed.
Cash runway and the debt wall
Cash & investments$15.2M
Debtnone
Net cash$15.2M
Cash runway2.2 years
Sensus Healthcare is burning cash: its operations consume cash, a free cash flow of −$7.0M a year at the current rate against $15.2M of cash and investments: a runway of about 2.2 years before any new financing.
Where the cash came from and went
From profit to cash
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
Quarter
Receivable days
Inventory days
Payable days
Cash conversion cycle
Q2 2026
104
1046
235
915
Q1 2026
128
582
150
559
Q4 2025
143
417
136
425
Q3 2025
147
281
121
306
Q2 2025
191
230
113
307
Q1 2025
204
226
118
312
Q4 2024
129
170
68
232
Q3 2024
183
316
93
407
Every quarter
Quarter
Operating cash flow
Capital spending
Buybacks
Shares issued
Cash drawn (+) / kept (−)
Free cash flow
Q2 2026
−$3.1M
−$8K
—
—
$3.1M
−$3.1M
Q1 2026
−$3.8M
−$3K
—
—
$3.8M
−$3.8M
Q4 2025
−$2.2M
−$158K
—
—
$2.4M
−$2.4M
Q3 2025
$2.3M
−$4K
—
—
−$2.3M
$2.3M
Q2 2025
$3.1M
−$27K
—
—
−$3.1M
$3.1M
Q1 2025
−$2.7M
−$7K
−$300K
—
$3.0M
−$2.7M
Q4 2024
−$827K
$297K
—
$33K
$502K
−$530K
Q3 2024
$4.0M
−$337K
—
$17K
−$3.6M
$3.6M
Sensus Healthcare: income statement and cash flow
Sensus Healthcare, Q2 2026: revenue $2.3M (-69% year over year), operating margin -138.9%. The chart follows the revenue to costs, profit and cash.
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.